Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06412978 · ClinicalTrials.gov registry record · NA
Post-Operative Cesarean Section Cosmesis
A NA study of Cesarean Delivery, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT06412978: Recruiting NA study of Cesarean Delivery, sponsored by Wake Forest University Health Sciences.
NCT06412978 is a NA study of Cesarean Delivery that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 52 participants, below the 3,478-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06412978, a NA study of Cesarean Delivery, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to base the choice of surgical technique.
Primary Outcome
Scars will be digitally photographed by study staff and scored by 2 independent judges (attending Obstetricians) according to the SCAR scale validated by Kantor with scores ranging from 0 (best) to 15 (worst).
Conditions Studied
Interventions
- PROCEDURE absorbable subcuticular polyglycolic acid staples (INSORB)
- PROCEDURE subcuticular, polyglecaprone suture (Monocryl)
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06412978 shows while recruiting
NCT06412978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 3,478-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cesarean Delivery appearing as the primary indexed condition, and to 2 interventions - of which absorbable subcuticular polyglycolic acid staples (INSORB) is the first listed.
NCT06412978 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06412978 about?
NCT06412978 is a clinical study titled "Post-Operative Cesarean Section Cosmesis". Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to b...
What is the current status of trial NCT06412978?
This trial is currently recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2024-09-05. Estimated completion is 2026-10.
What conditions does trial NCT06412978 study?
This clinical trial studies the following conditions: Cesarean Delivery.
What interventions are being tested in trial NCT06412978?
The interventions under investigation include: absorbable subcuticular polyglycolic acid staples (INSORB) (PROCEDURE), subcuticular, polyglecaprone suture (Monocryl) (PROCEDURE).
Who is sponsoring clinical trial NCT06412978?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06412978 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06412978's enrollment target sits among peer trials
52 10th of 10 higher than 1 of 10 other Cesarean Delivery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Delivery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
RECRUITING · NA
-
IC-CS Risk: Patient Outcomes
ACTIVE NOT RECRUITING · NA
-
Delayed Cord Clamping at Term Cesarean
COMPLETED · NA
-
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI